Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation

World Journal of Surgery

Volumn 31, Issue 12, 2007, Pages 2309-2314

  Verburg, Frederik A ^a,c   De Keizer, Bart ^a   Lam, Marnix G E H ^a   De Klerk, J M H ^a,b   Lips, Cornelis J M ^a   Borel Rinkes, Inne H M ^a   Van Isselt, Johannes W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN;

AGED; ARTICLE; CANCER PATIENT; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SCINTIGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; UTERINE CERVIX CANCER;

ADENOCARCINOMA, PAPILLARY; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 36849038367     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9257-2     Document Type: Article

References (30)

1. Jonklaas J, Sarlis NJ, Litofsky D, et al. (2006) Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16(12):1229-1242
2. Machens A, Hinze R, Thomusch O, et al. (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26(1):22-28
3. Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338(5):297-306
4. Schlumberger MJ, Pacini F (2003) Thyroid Tumors. Paris: Editions Nucleon
5. Tsang RW, Brierley JD, Simpson WJ, et al. (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82(2):375-388
6. 131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 83(8):2675-2680
7. TNM (1997) Classification of malignant tumors. 5th edition. Berlin: Springer
8. 131I scintigraphy. Nucl Med Commun 21(6):529-532
9. de Keizer B, Koppeschaar HP, Zelissen PM, et al. (2001) Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin. Eur J Nucl Med 28(2):198-202
10. Verburg FA, de Keizer B, Lips CJ, et al. (2005) Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol 152(1):33-37
11. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104(6):947-953
12. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418-428
13. Sherman SI, Brierley JD, Sperling M, et al. (1998) Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome: National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83(5):1012-1021
14. Simpson WJ, McKinney SE, Carruthers JS, et al. (1987) Papillary and follicular thyroid cancer: prognostic factors in 1,578 patients. Am J Med 83(3):479-488
15. Beasley NJP, Lee J, Eski S, et al. (2002) Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 128(7):825-828
16. Noguchi M, Earashi M, Kitagawa H, et al. (1992) Papillary thyroid cancer and its surgical management. J Surg Oncol 49(3):140-146
17. Scheumann GF, Gimm O, Wegener G, et al. (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18(4):559-567
18. DeGroot LJ, Kaplan EL, McCormick M, et al. (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71(2):414-424
19. McConahey WM, Hay ID, Woolner LB, et al. (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61(12):978-996
20. Hughes CJ, Shaha AR, Shah JP, et al. (1996) Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18(2):127-132
21. Leboulleux S, Rubino C, Baudin E, et al. (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90(10):5723-5729
22. Sugitani I, Kasai N, Fujimoto Y, et al. (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135(2):139-148
23. Anonymous (2002) Classification of Malignant Tumors. 6th edition. New York: Wiley-Liss
24. Salvatori M, Rufini V, Reale F, et al. (2003) Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27(7):770-775
25. Gulec SA, Eckert M, Woltering EA (2002) Gamma probe-guiolced lymph node dissection ('gamma picking) in differentiated thyroid carcinoma. Clin Nucl Med 27(12):859-861
26. Pereira JA, Jimeno J, Miquel J, et al. (2005) Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138(6):1095-1100
27. Pak H, Gourgiotis L, Chang WI, et al. (2003) Role of metastasectomy in the management of thyroid carcinoma: the NIH experience. J Surg Oncol 82(1):10-18
28. Pacini F, Cetani F, Miccoli P, et al. (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18(4):600-604
29. Solans R, Bosch JA, Galofre P, et al. (2001) Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 42(5):738-743
30. Kloos RT, Duvuuri V, Jhiang SM, et al. (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87(12):5817-5820